HUM's surging premiums, Medicare Advantage growth and CenterWell expansion bolster its prospects, but rising benefit costs and expenses pose challenges.

Big Tech earnings and the 2026 midterms will test whether Wall Street still rewards rising AI capex - or starts separating the winners.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Retirement planning gets harder when healthcare coverage becomes a moving target. A familiar insurance card can mean access to trusted doctors, predictable prescription costs, and benefits that help stretch a fixed income.

First Citizens Bank and Trust Co. bought a new stake in Humana Inc. (NYSE: HUM) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 2,106 shares of the insurance provider's stock, valued at approximately $804,000. Several other institutional investors and hedge funds

When Humana sends a plan-exit notice this fall, most members will scan it for a replacement option and move on. But buried in that letter is a federal right with an expiration date that could matter far more than any plan Humana offers instead.

HUM's CenterWell venture with BlackRock brings $2.8 billion in capital, easing balance sheet liabilities and supporting clinic expansion.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.